Resultados de la búsqueda 561-570 of 2764 for Vaccination

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Despite not needing therapy, these patients have significant immune dysfunction. This may lead to an increased risk of serious infections requiring ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate a low-cost Contrast Enhanced Digital Mammogram (CEDM) protocol as a supplemental screening method to standard ...

  4. Neurología - Ensayos clínicos

    ... vaccinations. Cerebral Spinal Fluid Evaluation in Individuals Who Have Idiopathic Normal Pressure Hydrocephalus (INPH). Rochester, Minn. The purpose of this ...

  5. Carcinoma hepatocelular - Etapas - Mayo Clinic

    Hepatitis B vaccine. U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/hepatitis-b/vaccination/index.html. Accessed Feb. 7, 2025. Feldman ...

  6. Oncología (médica) - Ensayos clínicos

    A personalized neoantigen peptide vaccine containing up to 20 unique peptides will be manufactured for each qualifying patient based on the results. Breath ...

  7. Oncología (médica) - Ensayos clínicos

    The primary purpose of the pilot study is to evaluate the safety and tolerability of an autologous dendritic cells (DC) vaccine delivered by intra-tumoral ...

  8. Neurología - Ensayos clínicos

    A Study to Evaluate the Spectrum of Healthy Pediatric Inflammatory Responses to Vaccinations ... vaccinations. Numeración de páginas Estudios clínicos. Anterior ...

  9. Neurología - Ensayos clínicos

    A Study to Evaluate the Spectrum of Healthy Pediatric Inflammatory Responses to Vaccinations ... Rochester, Minn. The purpose of this study is to understand the ...

  10. Oncología (médica) - Ensayos clínicos

    A personalized neoantigen peptide vaccine containing up to 20 unique peptides will be manufactured for each qualifying patient based on the results. Immune ...